Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050222

Director sold 10,200 shares at $0.67 ($6,834)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-22 Sale : show line 1 in the form 10b5-1 −10,200 $0.67 $6,834 274,773 D
Open-market sales · 10,200 sh · avg $0.67 · $6,834

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-19 Grant or award : show line 2 in the form 10b5-1 Stock Option +85,000 85,000 D
Loading xslF345X05/doc4.xml…